Skip to main navigation Skip to search Skip to main content

Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers

  • R. L. Piekarz
  • , R. Frye
  • , M. Turner
  • , J. Wright
  • , S. Allen
  • , M. H. Kirschbaum
  • , J. Zain
  • , M. Prince
  • , L. Hutchins
  • , L. C. Showe
  • , W. D. Figg
  • , T. Fojo
  • , S. E. Bates

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)29-31
Number of pages3
JournalHaematologica Reports
Volume2
Issue number13
StatePublished - 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: Clinical activity and molecular markers'. Together they form a unique fingerprint.

Cite this